These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 618383)

  • 1. Comparison of effects of nitroprusside and prazosin on left ventricular function and the peripheral circulation in chronic refractory congestive heart failure.
    Awan NA; Miller RR; Mason DT
    Circulation; 1978 Jan; 57(1):152-9. PubMed ID: 618383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine, and nitroglycerin on cardiac function and peripheral circulation.
    Miller RR; Vismara LA; Williams DO; Amsterdam EA; Mason DT
    Circ Res; 1976 Jul; 39(1):127-33. PubMed ID: 819179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiocirculatory actions of trimazosin and sodium nitroprusside in ischemic heart disease.
    Awan NA; Hermanovich J; Vera Z; Amsterdam EA; Mason DT
    Clin Pharmacol Ther; 1982 Mar; 31(3):290-6. PubMed ID: 7060312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.
    Miller RR; Vismara LA; Zelis R; Amsterdam EA; Mason DT
    Circulation; 1975 Feb; 51(2):328-36. PubMed ID: 1112013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
    Awan NA; Miller RR; DeMaria AN; Maxwell KS; Neumann A; Mason DT
    Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure.
    Mehta J; Iacona M; Feldman RL; Pepine CJ; Conti CR
    Am J Cardiol; 1978 May; 41(5):925-30. PubMed ID: 645603
    [No Abstract]   [Full Text] [Related]  

  • 7. Differences in hemodynamic effects of nitroprusside and prazosin in severe chronic congestive heart failure: evidence for a direct negative chronotropic effect of prazosin.
    Packer M; Meller J; Gorlin R; Herman MV
    Am J Cardiol; 1979 Aug; 44(2):310-7. PubMed ID: 463769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
    Mauri F; Gronda E; Bossi M; Rovelli F
    G Ital Cardiol; 1980; 10(4):414-23. PubMed ID: 7439582
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure.
    Bertel O; Burkart F; Bühler FR
    Am Heart J; 1981 May; 101(5):529-33. PubMed ID: 7223592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT
    Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alterations in the sympathetic nervous activity during vasodilator therapy by nitroprusside and prazosin in patients with congestive heart failure (author's transl)].
    Yui Y; Nakajima H; Sakurai K; Wakabayashi A; Kawai C
    Kokyu To Junkan; 1981 Jul; 29(7):723-6. PubMed ID: 7291740
    [No Abstract]   [Full Text] [Related]  

  • 12. Importance of neuroendocrine regulators of vascular tone and integral adrenoreceptor interaction during oral vasodilator therapy of severe congestive heart failure with prazosin.
    Awan NA; Beattie JM; Evenson ME; Needham KE; Mason DT
    J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S176-80. PubMed ID: 6175836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic advantage of combined administration of oral ibopamine and nitroprusside in patients with ischemic and idiopathic congestive cardiomyopathy.
    Dei Cas L; Fappani A; Riva S; Metra M; Cicogna R; Manca C; Visioli O
    Clin Cardiol; 1985 Aug; 8(8):427-32. PubMed ID: 4028536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
    Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT
    Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasodilator therapy for congestive heart failure.
    Dillon TR; Janos GG; Meyer RA; Benzing G; Kaplan S
    J Pediatr; 1980 Apr; 96(4):623-9. PubMed ID: 7359264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.
    Hayashi H; Sassa H; Oba M; Fukaya T; Okubo M; Niwa T; Matsui E
    Jpn Heart J; 1980 Nov; 21(6):827-36. PubMed ID: 7007686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of refractory congestive heart failure with prazosin.
    Awan NA; Evenson MK; Needham KE; Mason DT
    Am Heart J; 1981 Sep; 102(3 Pt 2):626-34. PubMed ID: 6267922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative hemodynamic effect of sodium nitroprusside and prazosin hydrochloride in patients with cardiac insufficiency following acute myocardial infarction].
    López-Sendón J; Coma Canella I
    Rev Esp Cardiol; 1981; 34(1):55-61. PubMed ID: 7280350
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined dopamine and nitroprusside therapy in congestive heart failure. Greater augmentation of cardiac performance by addition of inotropic stimulation to afterload reduction.
    Miller RR; Awan NA; Joye JA; Maxwell KS; DeMaria AN; Amsterdam EA; Mason DT
    Circulation; 1977 Jun; 55(6):881-4. PubMed ID: 858184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy.
    Laslett LJ; DeMaria AN; Amsterdam EA; Mason DT
    Arch Intern Med; 1978 May; 138(5):819-20. PubMed ID: 646547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.